Rajiv Kumar Jha

ORCID: 0000-0001-5151-9767
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer-related molecular mechanisms research
  • Neuropeptides and Animal Physiology
  • Epigenetics and DNA Methylation
  • RNA Research and Splicing
  • Nanoparticle-Based Drug Delivery
  • RNA modifications and cancer
  • Cancer, Stress, Anesthesia, and Immune Response
  • Hedgehog Signaling Pathway Studies
  • Cancer Mechanisms and Therapy
  • Cervical and Thoracic Myelopathy
  • Dendrimers and Hyperbranched Polymers
  • Liver physiology and pathology
  • Bone Tumor Diagnosis and Treatments
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Protease and Inhibitor Mechanisms
  • Connective Tissue Growth Factor Research
  • Sarcoma Diagnosis and Treatment
  • MicroRNA in disease regulation
  • Proteoglycans and glycosaminoglycans research
  • Biomarkers in Disease Mechanisms
  • Piperaceae Chemical and Biological Studies
  • Amino Acid Enzymes and Metabolism
  • Receptor Mechanisms and Signaling
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Chemokine receptors and signaling

Xi'an Medical University
2013-2023

Center for Cancer Research
2022

Beijing Friendship Hospital
2022

Xi'an Jiaotong University
2011-2012

First Affiliated Hospital of Xi'an Jiaotong University
2009-2011

First Hospital of Xi'an
2009

Combination chemotherapy has been proven to be an efficient strategy for the treatment of prostate cancer (PCA). However, pharmacokinetic distinction between drugs is insurmountable barrier realization their synergistic use against cancer. To overcome disadvantages combination in PCA, targeted nanoparticles (NPs), which can codeliver docetaxel (DOC) and doxorubicin (DOX) at optimal proportions, have designed. The DOC DOX codelivery (DDC NPs) were constructed by hyaluronic acid (HA) cationic...

10.3389/fphar.2019.01436 article EN cc-by Frontiers in Pharmacology 2019-12-18

Background: Combination chemotherapy plays an important role in the clinical therapy of non-small cell lung cancer (NSCLC).However, pharmacokinetic differences between drugs are insurmountable barrier traditional treatment.For synergistic NSCLC, nanoparticles (EDS NPs) loaded with both EGFR inhibitor and doxorubicin (DOX) were designed prepared.Methods: Erlotinib, apatinib icotinib evaluated for optimal combination DOX treatment NSCLC via CCK-8 assay.Then cationic amphipathic starch (CSaSt)...

10.7150/ijms.39172 article EN cc-by-nc International Journal of Medical Sciences 2020-01-01

Objective: The long-noncoding RNAs (lncRNAs) have been identified as key players in diverse cellular processes non-small cell lung cancer (NSCLC). However, the understanding of biological functions and detailed mechanisms lncRNAs is still limited. Herein, lncRNA susceptibility candidate 9 (CASC9) on NSCLC progression investigated. Materials Methods: Expressions CASC9, HuR division cycle 6 (CDC6) tissues were detected with quantitative real-time polymerase chain reaction (qRT-PCR). counting...

10.2147/cmar.s268375 article EN cc-by-nc Cancer Management and Research 2020-09-01

Polyamine biosynthesis is regulated by ornithine decarboxylase (ODC), which transcriptionally activated c-Myc. A large library was screened to find molecules that potentiate the ODC inhibitor, difluoromethylornithine (DFMO). Anthranilic acid derivatives were identified as DFMO adjunct agents. Further studies far upstream binding protein 1 (FUBP1) target of lead compound 9. FUBP1 a single-stranded DNA/RNA and master controller specific genes including c-Myc p21. We showed 9 does not inhibit...

10.1021/acs.jmedchem.2c01350 article EN Journal of Medicinal Chemistry 2022-11-16

Fibronectin and CD44v6 are involved in tumor invasion metastasis. We examined fibronectin expression normal liver cancer by immunohistochemistry. was identified 37.5% of specimens. Well-differentiated tumors expansive growth were associated with continuous periacinar, or cytoplasmic periacinar expression; poorly differentiated invasive showed interrupted vascular mesenchymal expression. absent controls but observed 67.5% cancers. Increased more common poor clinical characteristics. FN...

10.1080/07357900802375753 article EN Cancer Investigation 2009-01-01

To investigate the effects of piperlongumine (PL) and vitamin C (VC) on signal transducer activator transcription 3 (STAT3) signalling in gastric cancer cell lines.In vivo tumour xenograft anticancer assays were undertaken to confirm activity PL. Cell viability, flow cytometry Western blot evaluate PL, VC combinations PL AGS KATO III cells.Both induced apoptosis inhibited proliferation cells. These dependent reactive oxygen species (ROS). effectively suppressed STAT3 activation while caused...

10.1177/03000605221093308 article EN Journal of International Medical Research 2022-04-01

[b]Background[/b] The aim of this study was to evaluate the feasibility treating vertebral compression fractures using an autonomously developed nitinol memory alloy stent. [b]Material and Methods[/b] Thoracolumbar specimens from adult human cadavers were made into models fractures. divided group A, which received percutaneous kyphoplasty (PKP), balloon dilation, stent implantation (PKP + group); B, vertebroplasty (PVP) direct a (PVP C, PKP, bone cement polymethylmethacrylate (PMMA) group)....

10.12659/msmbr.890835 article EN Medical science monitor basic research/Medical science monitor. Basic research 2014-05-28

At present, the clinical diagnosis of and treatment methods for hepatic carcinoma still fail to fully meet needs patients. The integrated theranostic system, in which functional materials are used load different active molecules, created a new developmental direction combination carcinoma, realizing synchronization treatment. In this study, polydopamine (PDA), has functions self-assembly, encapsulation, photothermal conversion, photoacoustic interaction, was as carrier material. IR780,...

10.3389/fonc.2021.750807 article EN cc-by Frontiers in Oncology 2021-09-17

Abstract this research was developed to investigate the expression level of miR520a-5p in serum fetal growth restriction (FGR) and role its target genes, mitogen-activated protein kinase (MAPK) 1 (MEK1), pathogenesis FGR. Thirty cases FGR group 30 normal birth weight (control group) were selected. MiR520a-5p genes MEK1 MAPK mRNA two groups detected by RT‒PCR. The levels determined Western blotting. Spearman grade correlation used analyze between expression. Compared with control group,...

10.21203/rs.3.rs-2414902/v1 preprint EN cc-by Research Square (Research Square) 2023-02-23
Coming Soon ...